We are live on ! Find out more
NXTC icon

NextCure
NXTC

52 hedge funds and large institutions have $34.3M invested in NextCure in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $1.11M | Put options by funds: $687K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

2% more funds holding

Funds holding: 51 → 52 (+1)

0.24% more ownership

Funds ownership: 4.34% → 4.58% (+0.24%)

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

38% less capital invested

Capital invested by funds: $55.2M → $34.3M (-$20.9M)

Holders
52
Holders Change
+1
Holders Change %
+1.96%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
15
Closed
4
Calls
$1.11M
Puts
$687K
Net Calls
+$425K
Net Calls Change
-$2.25M

Top Buyers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
+$3.37M
2
Millennium Management
Millennium Management
New York
+$429K
3
Citadel Advisors
Citadel Advisors
Florida
+$343K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$225K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$211K

Top Sellers

Rank Fund Capital Flow
1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$511K
2
IC
Ikarian Capital
Texas
-$336K
3
BCM
Bridgeway Capital Management
Texas
-$297K
4
Renaissance Technologies
Renaissance Technologies
New York
-$262K
5
Bank of America
Bank of America
North Carolina
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
ExodusPoint Capital Management
New York
$137K -$141K -2,763 -40%
FIA
27
FNY Investment Advisers
New York
$132K +$204K +4,000 New
Northern Trust
28
Northern Trust
Illinois
$119K +$4.33K +85 +2%
Morgan Stanley
29
Morgan Stanley
New York
$117K -$12.5K -246 -7%
MA
30
Minerva Advisors
Pennsylvania
$87K – – –
KAM
31
Krensavage Asset Management
New York
$86K +$1.27K +25 +1%
Group One Trading
32
Group One Trading
Illinois
$83K +$128K +2,508 New
Franklin Resources
33
Franklin Resources
California
$68K +$1.58K +31 +2%
PFMU
34
Privium Fund Management (UK)
United Kingdom
$67K +$104K +2,033 New
AG
35
Algert Global
California
$63K – – –
HSBC Holdings
36
HSBC Holdings
United Kingdom
$51K -$612 -12 -0.8%
TRCT
37
Tower Research Capital (TRC)
New York
$45K +$34.9K +684 +100%
CSS
38
Cubist Systematic Strategies
Connecticut
$33K +$51.7K +1,014 New
Charles Schwab
39
Charles Schwab
California
$28K – – –
HP
40
Harbourvest Partners
Massachusetts
$28K – – –
UBS Group
41
UBS Group
Switzerland
$27K +$2.75K +54 +7%
JP Morgan Chase
42
JP Morgan Chase
New York
$14K -$122K -2,385 -85%
Bank of America
43
Bank of America
North Carolina
$10K -$153K -3,005 -91%
O
44
OrbiMed
New York
$7.46K – – –
CG
45
Cutler Group
California
$2K – – –
Northwestern Mutual Wealth Management
46
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$1.06K -$1.68K -33 -51%
Citigroup
48
Citigroup
New York
$1K -$408 -8 -23%
CUAMC
49
China Universal Asset Management Company
China
$1K +$1.12K +22 New
Assenagon Asset Management
50
Assenagon Asset Management
Luxembourg
– -$511K -9,053 Closed
1
2
3

NXTC Hedge Fund Activity: Q3 2022 in Review

52 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q3 2022, worth a combined $34.3M — down 38% from $55.2M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NXTC positions and 4 closed out — a net gain of 1 holder — while 13 added to existing stakes and 15 trimmed.

The largest buyer was K2 Principal Fund, adding an estimated $3.37M. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $511K sold.

  • 52 institutional investors held NextCure (NXTC) as of Q3 2022, up from 51 in Q2 2022.
  • Funds reported $34.3M of NextCure stock for Q3 2022, down 38% quarter-over-quarter.
  • 5 funds opened new NextCure positions in Q3 2022 and 4 closed out, a net change of +1 holder.
  • The largest NextCure buyer in Q3 2022 was K2 Principal Fund, an estimated $3.37M added.
  • The largest NextCure seller in Q3 2022 was Assenagon Asset Management, an estimated $511K sold.

Based on aggregated 13F filings for Q3 2022.